1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68:394-424, 2018.
2. Tomita N, Ishida H, Tanakaya K, Yamaguchi T, Kumamoto K, Tanaka T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer. Int J Clin Oncol, 26:1353-1419, 2021.
3. D G. Die Lymphgefaesse des Rectums und Anus. Arch Anat Physiol, 7:240-256, 1895.
4. Hojo K, Sawada T, Moriya Y. An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum, 32:128-133, 1989.
5. Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum, 32:307-315, 1989.
6. Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, et al. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum, 44:1274-1280, 2001.
7. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum, 49:1663-1672, 2006.
8. Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, et al. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212):A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg, 266:201-207, 2017.
9. Perez RO, São Julião GP, Vailati BB, Fernandez LM, Mattacheo AE, Konishi T. Lateral Node Dissection in Rectal Cancer in the Era of Minimally Invasive Surgery:A Step-by-Step Description for the Surgeon Unacquainted with This Complex Procedure with the Use of the Laparoscopic Approach. Dis Colon Rectum, 61:1237-1240, 2018.
10. Schaap DP, Boogerd LSF, Konishi T, Cunningham C, Ogura A, Garcia-Aguilar J, et al. Rectal cancer lateral lymph nodes:multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg, 108:205-213, 2021.
11. Liang JT. Technical feasibility of laparoscopic lateral pelvic lymph node dissection for patients with low rectal cancer after concurrent chemoradiation therapy. Ann Surg Oncol, 18:153-159, 2011.
12. Ogura A, Akiyoshi T, Nagasaki T, Konishi T, Fujimoto Y, Nagayama S, et al. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy. World J Surg, 41:868-875, 2017.
13. Park JA, Choi GS, Park JS, Park SY. Initial clinical experience with robotic lateral pelvic lymph node dissection for advanced rectal cancer. J Korean Soc Coloproctol, 28:265-270, 2012.
14. Bae SU, Saklani AP, Hur H, Min BS, Baik SH, Lee KY, et al. Robotic and laparoscopic pelvic lymph node dissection for rectal cancer:short-term outcomes of 21 consecutive series. Ann Surg Treat Res, 86:76-82, 2014.
15. Ishizaki T, Mazaki J, Kasahara K, Udo R, Tago T, Nagakawa Y. Robotic versus laparoscopic approach for minimally invasive lateral pelvic lymph node dissection of advanced lower rectal cancer:a retrospective study comparing short-term outcomes. Tech Coloproctol, 27:579-587, 2023.
16. Lee TH, Kwak JM, Yu DY, Yang KS, Baek SJ, Kim J, et al. Lower Incidence of Postoperative Urinary Retention in Robotic Total Mesorectal Excision for Low Rectal Cancer Compared with Laparoscopic Surgery. Dig Surg, 39:75-82, 2022.
17. Nakanishi R, Yamaguchi T, Akiyoshi T, Nagasaki T, Nagayama S, Mukai T, et al. Laparoscopic and robotic lateral lymph node dissection for rectal cancer. Surg Today, 50:209-216, 2020.
18. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol, 20:207-239, 2015.
19. Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol, 25:1-42, 2020.
20. Yamaguchi T, Kinugasa Y, Shiomi A, Tomioka H, Kagawa H. Robotic-assisted laparoscopic versus open lateral lymph node dissection for advanced lower rectal cancer. Surg Endosc, 30:721-728, 2016.
21. Shin US, Nancy You Y, Nguyen AT, Bednarski BK, Messick C, Maru DM, et al. Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer. Ann Surg Oncol, 23:2249-2257, 2016.
22. Kim HJ, Choi GS, Park JS, Park SY, Lee HJ, Woo IT, et al. Selective lateral pelvic lymph node dissection:a comparative study of the robotic versus laparoscopic approach. Surg Endosc, 32:2466-2473, 2018.
23. Peacock O, Limvorapitak T, Bednarski BK, Kaur H, Taggart MW, Dasari A, et al. Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer:a Western perspective. Colorectal Dis, 22:2049-2056, 2020.
24. Jones K, Qassem MG, Sains P, Baig MK, Sajid MS. Robotic total meso-rectal excision for rectal cancer:A systematic review following the publication of the ROLARR trial. World J Gastrointest Oncol, 10:449-464, 2018.
25. Huang L, Yin Y, Liao Y, Liu J, Zhu K, Yuan X, et al. Risk factors for postoperative urinary retention in patients undergoing colorectal surgery:a systematic review and meta-analysis. Int J Colorectal Dis, 37:2409-2420, 2022.
26. Ochiai K, Kaneko M, Nozawa H, Kawai K, Hata K, Tanaka T, et al. Incidence of and risk factors for lymphocele formation after lateral pelvic lymph node dissection for rectal cancer:a retrospective study. Colorectal Dis, 22:161-169, 2020.